Gut Motility Supplements: What the Trials Used, and What They Found

There is a particular frustration in eating a normal meal and feeling it sit there for hours. Nothing hurts and nothing is blocked. Food simply moves through you slowly, and you have started to suspect the problem is not what you eat but how your gut moves it.

That suspicion is worth taking seriously. This guide covers how gut motility works, what slows it down, and which gut motility supplements have real human data at a dose you can trace to a study. It also tells you which popular options have almost none, including the one marketed hardest for exactly this.

Table of Contents

• What Gut Motility Actually Is
• The Migrating Motor Complex, Explained
• What Slows a Gut Down
• The Four Mechanisms of Motility Support
• The Evidence-Graded Supplement Table
• Artichoke and Ginger: The Strongest Human Data
• 5-HTP and the Serotonin Pathway: The Most Marketed, Least Proven
• Magnesium: Osmotic Support, Not a Prokinetic
• Peppermint Oil, STW 5, and Multi-Herb Options
• Fiber, Bulk, and Transit Time
• Why People Look Past Prescription Prokinetics
• The Vagal Tone Layer
• The Levers That Carry Most of the Effect
• Maintenance, and Why SIBO Comes Back
• What to Expect and When
• What We Recommend
• Frequently Asked Questions
• References

What Gut Motility Actually Is

Gut motility is the sum of the muscular contractions that move contents from your stomach to your colon. Two muscle layers in the gut wall do the work, and how well they coordinate decides how fast everything travels.

Two programs matter, and they are mutually exclusive:

• The fed pattern. While food is present, the gut mixes and grinds, exposing contents to acid, enzymes, and the absorptive surface.
• The fasting pattern. Once the gut is empty, it switches to a different program: the migrating motor complex.

Whole-gut transit varies widely between healthy people, so "slow" is a clinical judgment built from symptoms and timing, not one number on a lab report.

Eating switches the fasting program off. That single fact explains most of what follows.

The Migrating Motor Complex, Explained

The migrating motor complex is your gut's fasting-state cleaning cycle. It runs only when you are not eating, and repeats about every 90 to 120 minutes until food arrives [1].

It moves through four phases:

• Phase I: quiet. Very little contractile activity. The resting stretch of the cycle.
• Phase II: building. Irregular contractions appear and gradually increase.
• Phase III: the housekeeper. Strong, rhythmic contractions sweep the small intestine, pushing residual food, debris, and bacteria downstream. This is the phase that matters most for motility support.
• Phase IV: the handoff. A short transition back into phase I, and the timer restarts.

Phase III is the housekeeper sweep, and it is why meal spacing comes up in every serious conversation about motility [1][2].

What interrupts it

• Any calorie at all. A handful of nuts, a latte, or a few bites of a child's leftovers resets the program to the fed pattern [1].
• Sympathetic (fight-or-flight) drive. Stress physiology works against the parasympathetic signaling that supports normal transit.
• Common medications. Several prescription classes slow the whole gut, covered next.
• Constant grazing. If food lands every two hours, the cycle never reaches phase III.

Deloose and Tack later tied phase III to small intestinal bacterial overgrowth and to hunger signaling, with the hormone motilin as a key driver [2]. That is why motility and bacterial balance get discussed together.

One pediatric study also shows phase III responding to provocative stimuli, so a single tracing is a snapshot rather than a fixed personal setting [3].

The migrating motor complex only runs while your gut is empty. A schedule that never leaves it empty never lets the housekeeper finish.

What Slows a Gut Down

Most slow-gut stories are not a deficiency. They are an input problem. Here are the ones that come up most, including three prescription categories most people never hear about.

For context, functional dyspepsia, the clinical label for upper-gut symptoms with no obvious structural cause, affects roughly 10 percent of the population and is classified as a disorder of gut-brain interaction [5].

The behavioral ones

• Grazing. One of the most common and most fixable causes. Eat every two hours and the migrating motor complex never gets room to run.
• Stress. Sustained sympathetic drive is the opposite of the parasympathetic state that supports digestion [9].
• Inactivity. Movement supports transit. A sedentary day is a slow day.

The medication ones

Opioids. Opioid painkillers act on receptors in the gut wall that regulate contraction, so slowed transit is a predictable pharmacological consequence rather than a rare reaction. This guide did not find a reference that quantifies that effect, so treat it as a mechanism rather than a measured risk. If you take an opioid and your digestion has changed, that is a prescriber conversation rather than a supplement one.

Proton pump inhibitors. Acid suppression changes the chemical environment of the small intestine, which is a plausible route to altered bacterial balance in the upper gut. This guide did not find a study that measures that link directly, so treat it as a mechanism worth raising with your prescriber rather than an established finding. If you take a PPI long term and your digestion has changed, raise it with your prescriber. Our guide to low stomach acid symptoms covers the acid side.

GLP-1 receptor agonists. This is a common reason people start searching for motility help right now. A 2025 descriptive single-center case series used a wireless motility capsule in 10 patients on GLP-1 receptor agonists and found delayed gastric emptying in 80 percent of them [4]. Read that number carefully. It comes from 10 patients at one center. It describes what those clinicians observed in a small group, not a population rate, and it should never be read as one. These drugs are designed to slow stomach emptying, so if you take one and your digestion has changed, raise it with your prescriber. For the broader picture, see our evidence-graded weight management guide.

The physiological ones

Low thyroid function. Thyroid issues are among the recognized contributors to delayed gastric emptying [8], and thyroid hormone influences gut muscle activity, which is why thyroid status is among the first things a clinician checks when transit slows without an obvious cause.

Aging. Motility tends to slow with age.

Mood. In a large cross-sectional cohort, depression was associated with constipation [6]. Cross-sectional means it shows a relationship, not a direction, so read it as "these travel together."

The most common cause of a slow gut is not a missing nutrient. It is a schedule that never leaves the gut empty.

The Four Mechanisms of Motility Support

"Supports gut motility" covers four genuinely different jobs. Knowing which one a product is doing tells you whether it can help your situation.

1. Enteric and cholinergic nerve support. Your gut has its own nervous system, and acetylcholine is the main signal that drives contraction. Ingredients supporting cholinergic signaling can influence contraction strength and frequency, though most of this evidence is mechanistic or animal-based.
2. Serotonin-pathway signaling. Most of the body's serotonin sits in the gut, produced by enterochromaffin cells that integrate microbial and mechanical signals to modulate motility [10]. The mechanism is real. The human outcome data is not, and we grade it honestly below.
3. Gastric emptying and bile flow. This is where artichoke and ginger act. Our guide to improving bile flow covers that mechanism separately. A standardized artichoke and ginger formula such as Enzyme Science GI Motility Complex is built around that exact pairing.
4. Osmotic and bulk effects. Magnesium and fiber work here, and this is the most misunderstood category. They are not known to act on the migrating motor complex. They change water and volume in the colon, which changes how easy passage is, not how fast your small intestine sweeps.

For the wider map of how these pieces fit together, our digestion and gut health resource page collects the whole picture.

The Evidence-Graded Supplement Table

Below is every ingredient class with human data worth discussing, graded by the strength of that data. The tiers are the point. A human randomized trial is not the same as an animal study, and neither is the same as traditional use.

Ingredient class	What the human data shows	Studied protocol	Evidence tier
Standardized artichoke + ginger extract	Improved symptom scores versus placebo in 126 patients with functional dyspepsia [11]	2 capsules per day, split before lunch and dinner, for 4 weeks [11]	Human RCT
Artichoke leaf extract alone	Reduced mild dyspepsia symptoms [12]	Open-label, no placebo arm [12]	Human, open-label
Ginger (symptom relief)	Reduced gastrointestinal disturbances versus comparator herbs in a 200-patient randomized trial in patients on anti-tuberculosis treatment [13]	1 g ginger daily over a 3-month intervention with a 1-month washout [13]	Human RCT, specific population
STW 5 type multi-herb	Improved tolerance to gastric gas in 32 patients [14], mechanisms reviewed separately [15]	2 weeks of treatment [14]	Human RCT
Peppermint oil	No benefit over placebo for abdominal pain in a 228-child randomized trial [16]	8-week pediatric RCT, peppermint oil versus peppermint sweets versus placebo [16]	Human RCT, null result
Magnesium	Randomized trial evidence for constipation, with the osmotic mechanism described rather than measured [17]	Varies by salt form and study [17]	Review-level, efficacy supported
Fiber (psyllium and agave fructans)	Clinical response in functional constipation, but no change in whole-gut transit time, regional transit time, contractility, or cecal pH [18]	20-patient wireless motility capsule sub-study [18]	Small human trial, null on transit
5-HTP and serotonin-pathway support	No direct human motility trial identified [10]	Not established in humans for motility [10]	Thin: mechanistic only

Every protocol above is what the study did, not a recommendation for you. Where a trial reported no milligram figure, the table says so rather than filling the gap with a marketing number.

To see these classes as finished products, browse digestion and gastrointestinal support. The lowest cost way into the artichoke and ginger class is Enzymedica Gut Motility.

Artichoke and Ginger: The Strongest Human Data

If one ingredient class has the strongest human evidence behind it, this is it, and the evidence is narrower than the marketing suggests.

The anchor trial. A 2015 randomized, double-blind, placebo-controlled trial gave 126 patients with functional dyspepsia a standardized ginger and artichoke extract, 2 capsules per day split before lunch and dinner, for 4 weeks, and reported improved symptom scores versus placebo [11]. That capsule schedule is the detail that matters most, and it is the one a label rarely prints. Note what the trial does not give you: a milligram figure per capsule. Any product claiming to match "the clinical dose" should be read against that schedule.

The weaker sibling. An earlier open-label study found artichoke leaf extract reduced mild dyspepsia symptoms [12]. With no placebo arm, expectation is uncontrolled. That makes it supportive rather than confirmatory, which is why the table grades it lower.

Ginger alone. A 200-patient randomized trial compared ginger (1 g daily) with caraway and peppermint for gastrointestinal disturbances and reported reduced symptoms in the ginger and peppermint groups, most visibly during the washout phase [13]. Two caveats matter. The trial measured symptom relief rather than a transit or motility endpoint, despite the word in its title, and every participant was a pulmonary TB patient on anti-tuberculosis treatment whose gastrointestinal symptoms were caused by that treatment. Treat it as a signal in a specific population rather than a settled general result.

Two mechanisms explain the interest. Artichoke supports bile flow, and ginger is associated with faster gastric emptying. Neither ingredient treats a disease, and the artichoke plus ginger pairing has the best human trial behind it. Integrative Therapeutics Motility Activator is that pairing as a standalone product, taken as 1 capsule twice daily, which is the two-capsule-per-day schedule the anchor trial used [11].

5-HTP and the Serotonin Pathway: The Most Marketed, Least Proven

This is the most heavily marketed mechanism for gut motility, and it has the weakest direct human motility evidence of anything in this guide. That sentence is the most useful thing on this page, so here is the honest breakdown.

Why the mechanism is genuinely interesting

Roughly 90 percent of the body's serotonin is made in the gut. Enterochromaffin cells line the intestinal wall and act as an integration hub, reading microbial and mechanical signals and modulating serotonin release and motility in response [10]. This is current, credible science.

A mechanism is not an outcome. A plausible pathway tells you a supplement might do something. It does not tell you that it does.

What is missing

No direct human motility trial of 5-HTP was identified in preparing this guide. The evidence table grades it thin: mechanistic only, and that grade is accurate.

Several of the best-known motility products on the market are 5-HTP-based. That does not make them useless. It does mean the claim runs ahead of the human data, and you should know that before you spend money.

The safety concern nobody prints on the bottle

5-HTP is a serotonin precursor, so it raises serotonin availability. That is exactly why it carries an interaction risk.

• Do not combine 5-HTP with SSRI or SNRI antidepressants, or with any other serotonergic drug, without a clinician's sign-off. Pairing a serotonin precursor with a medication that keeps serotonin around longer is a recognized interaction concern in clinical practice. This guide did not find a trial that measures that interaction, which is exactly why the advice is to ask a pharmacist rather than to guess at a safe dose.
• A 2026 mechanistic study examined how L-tryptophan and 5-HTP self-assemblies interact with prebiotic membranes and neuronal cells and reported adverse interactions [19]. It is a laboratory study rather than a clinical trial, so read it as a reason for caution, not as proven human harm.
• Anyone taking prescription medication should run 5-HTP past a pharmacist first.

If a motility product's entire story is serotonin, the honest summary is this: interesting mechanism, thin human evidence, and a real drug-interaction caution.

Magnesium: Osmotic Support, Not a Prokinetic

Magnesium works, and differently from everything else on this page.

Magnesium is osmotic. It draws water into the bowel, which increases stool water content and makes passage easier [17]. A 2026 review reports randomized trial evidence of benefit in constipation, while warning that many magnesium claims are hyped and need stronger evidence [17].

Here is the distinction that matters. Magnesium is not known to support the migrating motor complex. It does not sweep the small intestine clean. It changes the colon side of the equation, which puts it in the constipation conversation more than the motility one.

Form matters, since salts differ in how much elemental magnesium they deliver and how they behave in the gut. And the dose response is a slope, not a switch. DaVinci Labs Magnesium Citrate is the citrate salt, and each capsule delivers 140 mg of elemental magnesium from 870 mg of magnesium citrate.

Peppermint Oil, STW 5, and Multi-Herb Options

Peppermint oil. A randomized trial in 228 children and adolescents with irritable bowel syndrome and functional abdominal pain tested peppermint oil capsules against peppermint sweets and against placebo, and found no advantage over placebo: treatment success was 44.0 percent on peppermint oil versus 37.3 percent on placebo, a difference the trial reported as not statistically significant [16]. Read the mechanism precisely: peppermint oil is described as an antispasmodic, not a prokinetic. It relaxes smooth muscle, which is aimed at cramping. That is a useful job, and a different one from speeding transit, and in this trial it did not outperform placebo in this population.

STW 5 type multi-herb formulas. A randomized trial in 32 patients with functional dyspepsia found improved tolerance to gastric gas after 2 weeks [14], and a separate review describes the formulation's mechanisms across functional gastrointestinal disorders [15]. Combining several mechanisms makes it harder to attribute the effect to any single ingredient, but the human trial data is real.

Fiber, Bulk, and Transit Time

Fiber has the most consistent clinical response of anything on this list for functional constipation, and it is generally described as working by bulk and water rather than nerve signaling.

A 2024 trial used a wireless motility capsule in 20 patients with functional constipation to compare agave fructans with psyllium and measured whole and regional transit time alongside pH. Both groups responded clinically, but the trial found no change in whole-gut transit time, regional transit time, contractility, or cecal pH, and it concluded that the clinical response was not associated with any improvement in transit [18]. That is the honest read: fiber helped these patients without changing how fast things moved. Note the outcome measured: transit time, which is a different thing from the migrating motor complex. Fiber changes the consistency and volume of what moves. It does not run the housekeeper sweep.

Why People Look Past Prescription Prokinetics

This section is context, not a sales pitch.

Metoclopramide is the only FDA-approved medication for gastroparesis, and it carries a real risk of extrapyramidal side effects, which are movement-related neurological effects that can become irreversible with long-term use [8]. That is why it is generally used short term and at the lowest effective dose.

The wider prokinetic class is not a clean alternative either. A 2026 review of evolving prokinetic therapy describes the marketed options as giving modest symptomatic relief, with long-term use limited by safety concerns [20]. Modest is the operative word.

So the honest picture: prescription prokinetics help some people somewhat, and their long-term use is constrained by side effects. That gap is why people search for nutritional support. It is also not a reason to avoid a medication your clinician has prescribed.

The Vagal Tone Layer

Your gut listens to your nervous system, and the tone of that conversation is measurable.

In irritable bowel syndrome, patients show reduced vagal tone with relative sympathetic hyperactivity [9]. In plain terms, the parasympathetic brake is weaker and the sympathetic accelerator is pressed.

That points at interventions that have nothing to do with a capsule:

• Slow breathing. Extending your exhale activates the parasympathetic branch. Our guide to calming your nervous system walks through the practical version.
• Meal-time calm. Eat without a screen and without a meeting. Digestion is a parasympathetic activity, and stress physiology suppresses it.
• Vagus-targeted neuromodulation. A 2026 translational review of transcutaneous auricular vagus nerve stimulation describes it as an emerging route for gastrointestinal disorders, moving from mechanism to clinic [21]. It is promising and not yet a standard home intervention.

The Levers That Carry Most of the Effect

No supplement can out-run a schedule that never leaves your gut empty. These four levers do more than any bottle on this page.

Space your meals

Because a full cycle is usually given as about 90 to 120 minutes [1], constant eating is the direct opposite of what the migrating motor complex needs. Aim for roughly four hours between meals, which gives at least one complete cycle room to finish.

Fast overnight

The overnight stretch is the longest uninterrupted window your gut gets, and it is when the housekeeper does its best work. Aim for a 12-hour gap between your last bite and your first. Most people break this without noticing, with a late dessert or a large drink that carries calories.

Support vagal tone

Slow breathing before meals, and eat in a calm state [9]. The mechanism is above, and the application takes five minutes.

Move, hydrate, and keep fiber steady

Activity supports transit, water makes fiber work, and a steady fiber intake is what the laxative evidence actually supports, though the measured benefit in the 2024 trial showed up in symptoms rather than in transit time or pH [18]. Magnesium belongs here too if the colon side is your main complaint [17].

Maintenance, and Why SIBO Comes Back

If you arrived here after treatment for small intestinal bacterial overgrowth, this section answers your actual question.

Recurrence is common. A 2025 systematic review and meta-analysis, posted as a preprint rather than a peer-reviewed paper, examined breath test performance, treatment response, and relapse in SIBO and intestinal methanogen overgrowth, and it reports lower relapse when prokinetic maintenance was used [22]. A 2026 critical review notes that current treatments for bacterial overgrowth offer only temporary relief with frequent relapses [7]. And a 2025 narrative review on eradicating SIBO in systemic sclerosis notes that disordered motility promotes microbial stasis, the mechanism connecting a slow gut to bacterial overgrowth [23].

That mechanism is why motility support gets discussed in a maintenance context. If the housekeeper sweep is weak, contents linger, and lingering contents are what bacteria feed on.

Our SIBO relapse prevention guide covers the full maintenance protocol, including prokinetic timing and duration. Nothing on this page treats SIBO. This is about supporting normal transit, which is a different and more honest claim.

What to Expect and When

Timelines are where supplement marketing gets most creative, so here is what the trials actually did.

In days:

• Very little. Nothing in this guide has an immediate effect on the migrating motor complex. The levers that change soonest are behavioral.
• Osmotic effects are the exception. Magnesium acts on the water content of stool rather than on the migrating motor complex, which is why it is graded separately [17]. This guide found no reference that puts a day figure on that change.

In weeks:

• The artichoke and ginger trial ran 4 weeks [11].
• The STW 5 trial ran 2 weeks [14].
• The fiber trial measured across its supplementation period and found no transit or pH change [18].

In months:

• Maintenance is a long game. Motility support after treatment is discussed in months rather than weeks, because the goal is a rhythm rather than a result.

Judging any of this at day three is judging noise.

What We Recommend

Four picks, each tied to a class covered above, and each checked against the live store for status, stock, and price on the day this was written. Three are the standardized artichoke and ginger family, which is where this guide found the strongest human data, and the fourth is the magnesium route for the colon side of the equation. Take an artichoke and ginger product if your complaint is food sitting heavy with upper gut fullness, and take the magnesium if your complaint is the colon side, harder or less frequent bowel movements. Each of these four was checked as live and in stock on the day this was written. All three artichoke and ginger picks support normal motility and transit, the magnesium pick supports normal bowel function, and none of them treats a condition or replaces a medication your clinician has prescribed.

Integrative Therapeutics, Motility Activator 60 Veg Capsules

A standardized artichoke and ginger extract taken as 1 capsule twice daily, which is the two-capsule-per-day schedule the anchor trial in this guide used [11]. The closest match here to the formulation with the strongest human data, so it is the place to start if you want the class the evidence actually supports.

$43.00 for 60 capsules

Enzyme Science, GI Motility Complex 60 Capsules

A triple standardized artichoke and ginger blend with apple cider vinegar, aimed at the gastric emptying and bile flow mechanism above rather than at the migrating motor complex. A fit for the reader whose main complaint is upper gut fullness and food that sits heavy.

$47.49 for 60 capsules

Enzymedica, Gut Motility 30 Capsules

The same artichoke and ginger class in a 30 capsule bottle at the lowest price of the three, for the reader who wants to try the evidence-backed class before committing to a larger supply.

$25.99 for 30 capsules

DaVinci Labs, Magnesium Citrate 90 Capsules

Magnesium citrate, the salt form behind the osmotic effect this guide separates from the migrating motor complex, at 140 mg of elemental magnesium per capsule. The pick if the colon side is your main complaint rather than upper gut fullness, and the one item here whose effect does not depend on the fasting cycle, since it acts on the water content of stool rather than on the migrating motor complex [17].

$19.30 for 90 capsules

One family is deliberately absent. The 5-HTP based motility products are not listed, because this guide grades that pathway as thin on direct human motility evidence and carrying a real drug-interaction caution, and a list like this follows the evidence rather than the marketing.

Frequently Asked Questions

What is the best supplement for gut motility?

By strength of human evidence, a **standardized artichoke and ginger extract** has the best data: a randomized, double-blind, placebo-controlled trial in 126 patients with functional dyspepsia, 2 capsules per day split before lunch and dinner, for 4 weeks [11]. STW 5 type multi-herb formulas also have randomized data [14]. **The most heavily marketed option, 5-HTP, has the weakest direct human motility evidence in this guide** [10]. Best means best evidence, not the loudest claim.

How do I know if my gut motility is slow?

You do not diagnose it yourself. The pattern that usually prompts a clinical conversation is food sitting heavy for hours, early fullness, and bowel movements that have become less frequent or harder to pass. If transit has changed suddenly, or comes with pain, vomiting, or weight loss, that is a clinician's question rather than a supplement question.

Is 5-HTP safe for motility?

It carries a real interaction caution. **5-HTP raises serotonin, so it should not be combined with SSRI or SNRI antidepressants or other serotonergic drugs without a clinician's sign-off.** A 2026 laboratory study reported adverse interactions between 5-HTP self-assemblies and prebiotic membranes and neuronal cells [19], and its direct human motility evidence is thin [10]. **This guide did not find a trial that measures that interaction**, which is why the advice is to ask a pharmacist rather than to guess at a safe dose.

How long do motility supplements take to work?

Plan on weeks, not days. The artichoke and ginger trial ran 4 weeks [11], and the STW 5 trial ran 2 weeks [14]. Magnesium acts on stool water rather than on the migrating motor complex, so it is the one item here that does not depend on the fasting cycle [17]. **This guide found no reference that puts a day figure on that change.** **Nothing here changes the migrating motor complex quickly**, because it is a rhythm rather than a level.

Can I take a motility supplement with a PPI or a GLP-1?

Ask your prescriber first, and the answer differs for each. Acid suppression may change the environment upper-gut bacteria live in, so a long-term PPI is worth reviewing with the clinician who prescribed it. **This guide found no study that measures that link directly.** For GLP-1 receptor agonists, a small single-center case series of 10 patients found delayed gastric emptying in 80 percent of them [4]. **Neither situation is one to self-manage with a supplement.**

Do motility supplements help after SIBO treatment?

This is where motility support gets discussed most, because recurrence after treatment is common [22] and disordered motility promotes microbial stasis [23]. The maintenance logic is to support normal transit so contents do not linger. **Nothing here treats SIBO or prevents its return.**

Are natural prokinetics as strong as prescription ones?

No, and that comparison is not the right one. Metoclopramide carries extrapyramidal side-effect risk [8], and marketed prescription prokinetics give modest symptomatic relief with long-term safety limits [20]. Nutritional support and prescription treatment are different tools with different risk profiles. **Neither replaces a clinician's judgment.**

References

1. Deloose E, Janssen P, Depoortere I, Tack J. The migrating motor complex: control mechanisms and its role in health and disease. Nat Rev Gastroenterol Hepatol. 2012. PMID 22450306.
2. Deloose E, Tack J. Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling. Am J Physiol Gastrointest Liver Physiol. 2016. PMID 26660537.
3. Damrongmanee A, El-Chammas K, Fei L, Liu C, Santucci N, Kaul A. Effects of Provocative Testing on Phase III Migrating Motor Complex in Children. 2021. PMID 34224491.
4. Cymbal M, Naseem Z, Hoxha D, Garg S. Impact of GLP-1 Receptor Agonists on Whole-Gut Gastrointestinal Motility Using Wireless Motility Capsule: A Descriptive Single-Center Case Series. 2025. PMID 40761333.
5. Storr M, Andresen V, Frieling T, et al. S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD). 2026. PMID 42095009.
6. Ferdowsi M, Faraji N, Maroufizadeh S, Mansour-Ghanaei F, Joukar F. Relationship Between Depression and Constipation: A Cross-Sectional Health Report From the PERSIAN Guilan Cohort Study. 2026. PMID 42460241.
7. Shah A, Holtmann G, Gibson PR. Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth (SIBO). 2026. PMID 42146105.
8. Kumar G, Shah Y, Rooman U, et al. Progress in Gastroparesis Management: From Pharmacotherapy to Interventional Treatments. 2026. PMID 41809573.
9. Bai Y, Yu M, Weng C, Xu J, Zheng M, Lv B. Autonomic nervous system dysfunction in irritable bowel syndrome: pathophysiology and therapeutic implications. 2026. PMID 42325955.
10. Xiao Y, Louwies T, Mars RAT, et al. Enterochromaffin cells as a cellular integration hub for cooperative microbial signaling to modulate gut serotonin and motility. 2026. PMID 42636369.
11. Giacosa A, Guido D, Grassi M, Riva A, Morazzoni P, Bombardelli E, Perna S, Faliva MA, Rondanelli M. The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynara cardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial. 2015. PMID 25954317.
12. Marakis G, Walker AF, Middleton RW, Booth JC, Wright J, Pike DJ. Artichoke leaf extract reduces mild dyspepsia in an open study. Phytomedicine. 2002. PMID 12587688.
13. Latif A, Ahmad H, Bashir I. Comparative Study on the Prokinetic Effects of Ginger, Caraway, and Peppermint in Relieving Gastrointestinal Disturbances in Pulmonary TB Patients: A Clinical Trial. 2025. PMID 40421412.
14. Aguilar A, Alcala-Gonzalez L, Barber C, Santos J, Lobo B, Malagelada C, Serra J. Effect of STW 5-II (Iberogast-N) on Tolerance to Gastric Gas in Patients With Functional Dyspepsia. The IBO-2 Study. 2025. PMID 40684457.
15. Tursi A, Marinoni B, Privitera AC, Privitera L, Danese S. STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical Efficacy. 2025. PMID 39978315.
16. Vermeijden NK, van der Feen C, Groeneweg M, et al. Peppermint Oil and Sweets in Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain: A Randomized Trial. 2026. PMID 41610933.
17. Sankararaman S, Memel Z, Dubroff J, Rocha JP. Magnesium: Hype and Health Benefits. 2026. PMID 42484803.
18. Coss-Adame E, Arenas-Martínez JS, García-Cedillo MF, Nosthas LC, Bustillo-Armendriz G. The effect of fiber supplementation with agave fructans or psyllium plantago in symptoms of constipation and its relation with whole and regional transit time and pH. 2024. PMID 39223790.
19. Hazra R, Paul S, Nandi PK, Maity A, Layek S, Debnath A, Sarkar N. Elucidating the Adverse Interactions of L-Tryptophan and 5-Hydroxytryptophan Self-Assemblies with Prebiotic Membranes and Neuronal Cells: An Investigation Using Fluorescence Spectroscopy and Lifetime Imaging Microscopy. 2026. PMID 42284539.
20. Goyal O, Chowdhary R, Sehgal T, et al. Evolving prokinetic therapy: New targets and therapeutic opportunities in gastrointestinal motility disorders. 2026. PMID 42273241.
21. Cui J, Zhao J, Zhou S. Bridging the gap from mechanism to clinic: a translational perspective on taVNS for gastrointestinal disorders. 2026. PMID 42440937.
22. Choudhary AK, Hait A, Ganesan S, Howlader S, Periasamy P. SIBO and Intestinal Methanogen Overgrowth: Breath Test Performance, Treatment Response, and Relapse. A Systematic Review and Meta-Analysis. 2025. Europe PMC preprint PPR1136628. Preprint. Not peer reviewed; cited for recurrence figures only.
23. Radić M, Belančić A, Vučković M, et al. Eradication of Small Intestinal Bacterial Overgrowth in Systemic Sclerosis: Current Treatment and Perspectives. A Narrative Review. 2025. PMID 41462944.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.